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1 |  INTRODUCTION
We present the case of a patient with muscular dystrophy—de-
sminopathy—who underwent for 24 weeks on a supervised ex-
ercise and protein/creatine supplementation intervention. The 
results of the present case show that the interventions were safe 
and had a positive effect on muscle mass and quality of life.
Desminopathy is a neuromuscular disease caused by a 
mutation of DES, the gene encoding the intermediate fila-
ment desmin.1 Desmin primarily functions to provide struc-
ture within the sarcomere by connecting the contractile 
apparatus to the plasma membrane, nucleus and mitochon-
drial membranes of cardiac and skeletal muscle.2-4 Recently, 
67 different mutations of DES gene were described of which 
arginine 350 proline (A350P) was the most common.5 This 
mutation affects both cardiac and skeletal muscle and usually 
presents as weakness in the appendicular leg muscles before 
spreading proximally leading.1 The normal progression of 
the disease is increasing weakness resulting in paresis and 
wheelchair dependence.
To date, there are no treatments available for desminop-
athies; however, the application of exercise and nutritional 
strategies to minimize the progression of this disease and the 
secondary pathologies associated with it (ie, insulin resistance, 
cardiovascular risk due to physical inactivity), could provide 
significant value for these patients. There is substantial evi-
dence supporting the use of exercise and nutrition to improve 
quality of life in people with Duchenne muscular dystrophy.6,7 
However, in patients with desminopathy, it is not clear whether 
these strategies are beneficial or accelerate the progression of 
the disease. Thus, the present case study aimed to identify 
whether an exercise and nutritional regimen would be benefi-
cial in a patient with the A350P mutation in DES gene.
2 |  CASE PRESENTATION
A 49-year-old male of German descent diagnosed in 2006 
with desminopathy—with confirmation of a A350P mutation 
of the DES gene—was referred with the following symp-
toms: (a) muscular weakness in lower extremities, which 
were more severe in the left leg; (b) muscular weakness in 
upper left extremity (shoulder and shoulder girdle); and (c) 
recurrent falls every 2-3 months.
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The patient moved with the help of a cane and while 
walking presented a mix of slippage and waddling. 
Postural evaluation revealed anteversion of head, neck, 
and pelvis accompanied by hyperkyphosis of the dorsal 
column. Muscle strength testing8 revealed lower extrem-
ity muscle weakness, whereas upper extremity strength 
was normal.
The patient was consuming the following drugs: metformin 
hydrochloride (500 mg); clotiazepam (5 mg); olmesartan me-
doxomil (20 mg); escitalopram oxalate (10 mg); acetylsalicylic 
acid (100 mg); eszopiclone (3 mg); and allopurinol (100 mg), at 
presentation and throughout the intervention.
The intervention consisted of a 6-month nutritional pro-
gram and an exercise program for the final 3 months of the 
study. The purpose of the case study was to first determine 
whether exercise was safe, and second whether an exercise 
and nutritional supplementation plan could attenuate the pro-
gressive loss of muscle mass and improve quality of life of 
the patient.
2.1 | Nutritional intervention
Prior to the intervention, the amount and macronutrient 
content of the patient's diet was assessed. The initial as-
sessment determined that he consumed ~3.0 g/kg/d of car-
bohydrate, ~0.5 g/kg/d of fat, and ~1.5 g/kg/d of protein. 
Protein intake of the patient was within current recommen-
dations for his age; however, we sought to increase protein 
in the diet, as it has recently been suggested that ill patients 
should consume between 2.0 and 2.5 g/kg/d of protein.9 In 
addition, 3 grams/day creatine monohydrate (GNC) was 
added to the diet in an effort to increase lean mass and mus-
cle strength, since this is beneficial in patients with muscu-
lar dystrophy.10
Beyond the basic changes to the diet, the patient consumed 
31  g of casein (Muscletech Platinum, Bryan, TX, USA) 3 
times per week before going to sleep. In addition, the patient 
was supplemented with 22 g of whey protein (Dymatize ISO 
100) and 2 g of leucine (Leucine complex, GNC) after each 
exercise bout.
2.2 | Exercise intervention
The exercise intervention was divided in two parts: acute and 
chronic (Table 1). Acute exercises were performed to deter-
mine whether endurance or low-intensity resistance exercises 
would lead to significant muscle damage. The chronic exer-
cise intervention was designed after no significant increase 
in creatine kinase was detected following the acute interven-
tions. The supervised exercise program was performed for 
12 weeks and consisted of two different exercise protocols 
performed on separate days: (a) arm ergometer at 60% of 
maximal heart rate (HR) for 30 minutes, including a 5 min-
utes warm up and a 5 minutes cool down (Figure 1); and (b) 
blood flow restricted (50 mm Hg) resistance exercises: bicep 
curl, pull down, pull up, quadricep isometric, and hip abduc-
tion and adduction (Figure 2) (Table 1), involving 1 set of 30 
repetitions and 3 sets of 15 repetitions with a 30-second break 
between sets. During each exercise bout, the patient wore a 
Polar V800 HR monitor (Kempele) and was asked before the 
end of each exercise session to estimate the intensity of the 
training session utilizing the Borg rating of perceived exer-
tion scale.11
2.3 | Blood measurements
Blood sampling was performed at Clinica UC-CHRISTUS 
for analysis of metabolic and inflammatory markers, includ-
ing triglycerides (TG), total cholesterol, low-density lipopro-
tein cholesterol (LDL-c), high-density lipoprotein cholesterol 
(HDL-c), insulin, and glucose.
Blood creatine kinase (CK) levels were measured in 
the Ciencias del Deporte y Movimiento laboratory at 
the Universidad Finis Terrae) using a spectrophotometer 
(Reflotron® Plus, Roche Diagnostics).
T A B L E  1  Acute and chronic exercise, rating of perceived exertion (RPE), heart rate (HR), and blood creatine kinase (CK) levels
Type of exercise Time RPE HR
CK (U/L)
Pre Post 20 m Post 24 h
Cycle ergometer 30 15 109 113 117 66
Arm ergometer 30 15 101 102 107 103
Blood flow (50 mm Hg) restricted UE and LE 60 14 86 97 86 69
Treadmill (2 km/h) 20 12 95 93 103 105
Treadmill (3 km/h) 20 16 110
Chronic arm ergometer 30 15 ± 1 93 ± 3 – – –
Chronic blood flow (50 mm Hg) restricted UE and LE 60 13 ± 1 95 ± 4 – – –
Abbreviations: LE, lower extremity; UE, upper extremity.
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2.4 | Body composition
Body composition was measured at Clinica MEDS with a 
dual-energy X-ray absorptiometry (DXA, Hologic Discovery 
Wi). Waist circumference was measured in the laboratory.
2.5 | Timed up and go test
To assess the clinical mobility, the patient performed the 
timed up and go test.12
2.6 | Questionnaires
A series of questionnaires were completed by the patient to 
assess quality of life and independence including: (a) WHO 
quality of life-BREF (WHOQOL-BREF) (World Health 
Organization); (b) functional independence measure (FIM)13; 
and (c) multidimensional assessment of fatigue (MAF)14
2.7 | Creatine kinase
Baseline blood creatine kinase (CK) levels were normal and CK 
level remained unaltered both 20 minutes and 24 hours after an 
acute bout of cycle ergometry, arm ergometry, treadmill exer-
cise, and blood flow-restricted strength training (Table 1).
3 |  RESULTS
3.1 | Body composition
After the 24-week intervention, there was a 1.7 kg reduc-
tion in body mass, mostly due to a reduction in fat mass 
from 49.5 to 48 kg (Table 2). Fat-free mass only decreased 
0.1 kg, whereas waist circumference was decreased by 2 cm 
(Table 2).
3.2 | Blood analyses
Total cholesterol decreased 17 mg/dL after the intervention, 
mainly due to a reduction in HDL-c (11 mg/dl). There were 
no changes in HOMA-IR and TG in blood (Table 2).
3.3 | Timed up and go test
After the intervention, there was a 6.6% improvement in time 
to perform the timed up and go test (Figure 3). Despite this 
positive result, the patient remained at the same level of clas-
sification (ie, over 20 seconds).
3.4 | Quality of life questionnaires
In the abbreviated version of quality of life questionnaire, the 
patient improved their score by 25% (Figure 4A). In addition, 
there was a 24% decrease in fatigue sensation (Figure 4B) and 
a 5.3% increase in functional independence test (Figure 4C).
4 |  DISCUSSION
The results of the present case study revealed that acute and 
chronic low-intensity exercises were viable and safe in a pa-
tient with desminopathy (A350P mutation). In addition, the 
combination of a long-term exercise training and nutritional 
supplementation plan improved quality of life, physical func-
tion, and sensation of fatigue.
To date, it is not clear whether physical activity is ben-
eficial or harmful in people with desminopathy. To our 
knowledge, this is the first report to provide evidence that 
acute exercise did not induce muscle damage in a patient 
with A350P mutation in DES gene. An indirect marker of 
muscle injury (blood CK levels) was normal at baseline 
and not affected by low-intensity endurance or resistance F I G U R E  1  Image of arm cycle ergometer exercise
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exercise. In support of the hypothesis that exercise did not 
induce muscle injury, neither body weight supported nor 
impact exercise (walking of the treadmill at 3km/h) induced 
an increase in CK. These results are similar to previous 
studies performed in patients with other muscular dystro-
phies where assisted cycling and arm ergometer exercises 
were shown to be safe.15-18
The patient of the present study is in an advanced stage 
of his disease. At presentation, he walked with the help of 
a cane and for longer distances used a wheelchair. Thus, a 
second goal of this case study was to improve the quality 
of life through a targeted and evidence-based exercise and 
nutritional plan. Despite not demonstrating significant im-
provements in cardiovascular function and body composi-
tion, disease progression was minimized, and quality of life 
was improved. In fact, this protocol yielded a 25% decrease 
in fatigue and improved functional independence, similar to 
previous studies in patients with other myopathies.19,20 All 
F I G U R E  2  Images of blood flow 
restricted exercises. Bicep curl (A); pull 
down (B); pull up (C); quadricep isometric 
(D, F); and hip abduction and adduction (E)
(A) (B)
(C) (D)
(E) (F)
T A B L E  2  Body composition and blood measures
Subject characteristics PRE POST
Body mass (kg) 94 92.3
Fat mass (kg) 49.5 48
Fat-free mass (kg) 41.2 41.1
Waist circumference (cm) 116 114
Total cholesterol (mg/dL) 193 176
Triglycerides (mg/dL) 295 294
HDL-c (mg/dL) 38 27
LDL-c (mg/dL) 96 90
HOMA-IR 7.2 7.4
Abbreviations: HDL-c, high-density lipoprotein cholesterol; HOMA-IR, ho-
meostatic model assessment-insulin resistance; LDL-c, low-density lipoprotein 
cholesterol.
F I G U R E  3  Time (s) to perform timed up and go test
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together these results provide evidence that low-intensity ex-
ercise training in combination with a nutritional intervention 
plan is beneficial and, therefore, should be recommended to 
slow the progression and severity of this desminopathy.
A major limitation of the present report is that there were no 
measurements performed to test the independent effects of the 
nutritional plan after the first three months of the intervention; 
therefore, it was not clear whether the improvements reported 
by the patient were due to exercise, the nutrition intervention 
or a combination of both interventions. Further, it remains to 
be elucidated whether other exercise protocols (ie, higher in-
tensity exercises) are well tolerated by these patients. Lastly, it 
is not clear whether training the legs through treadmill exer-
cise or cycle ergometry would recruit more muscle mass and 
better improve functional results such as timed up and go test. 
Future studies should assess the independent effects of nutri-
tional supplements and exercise and the specific exercise used 
on progression of the disease, function, and quality of life.
In conclusion, this case report demonstrates that low-in-
tensity exercises are safe, even in advanced stages of desm-
inopathy. In addition, this study proved that a nutritional 
intervention (protein and creatine supplementation) in com-
bination with exercise training minimized progression of 
the disease, improved body composition, and quality of life. 
Therefore, we suggest that low-intensity exercise, greater 
dietary protein, and creatine monohydrate should be recom-
mended in patients with desminopathy.
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